| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8526262 | Biomedicine & Pharmacotherapy | 2018 | 9 Pages |
Abstract
The synergic effect observed with combination of these pyrazoles and doxorubicin deserves special attention in Claudin-low breast cancer subtype. This should be explored in order to improve treatment results and minimize side effects.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Silvia Saueressig, Josiane Tessmann, Rosiane Mastelari, Liziane Pereira da Silva, Julieti Buss, Natalia Vieira Segatto, Karine Rech Begnini, Bruna Pacheco, Cláudio Martin Pereira de Pereira, Tiago Collares, Fabiana Kömmling Seixas,